156 related articles for article (PubMed ID: 22511116)
1. Developmental immunotoxicity (DIT): assays for evaluating effects of exogenous agents on development of the immune system.
DeWitt JC; Peden-Adams MM; Keil DE; Dietert RR
Curr Protoc Toxicol; 2012 Feb; Chapter 18():Unit 18.15. PubMed ID: 22511116
[TBL] [Abstract][Full Text] [Related]
2. Current status of developmental immunotoxicity: early-life patterns and testing.
DeWitt JC; Peden-Adams MM; Keil DE; Dietert RR
Toxicol Pathol; 2012; 40(2):230-6. PubMed ID: 22109713
[TBL] [Abstract][Full Text] [Related]
3. Developmental immunotoxicology (DIT): windows of vulnerability, immune dysfunction and safety assessment.
Dietert RR
J Immunotoxicol; 2008 Oct; 5(4):401-12. PubMed ID: 19404874
[TBL] [Abstract][Full Text] [Related]
4. Approaches and considerations for the assessment of immunotoxicity for environmental chemicals: a workshop summary.
Boverhof DR; Ladics G; Luebke B; Botham J; Corsini E; Evans E; Germolec D; Holsapple M; Loveless SE; Lu H; van der Laan JW; White KL; Yang Y
Regul Toxicol Pharmacol; 2014 Feb; 68(1):96-107. PubMed ID: 24280359
[TBL] [Abstract][Full Text] [Related]
5. Methodologies for developmental immunotoxicity (DIT) testing.
Dietert RR; Holsapple MP
Methods; 2007 Jan; 41(1):123-31. PubMed ID: 17161309
[TBL] [Abstract][Full Text] [Related]
6. Developmental immunotoxicity (DIT): the why, when, and how of DIT testing.
Dietert RR; Dewitt J
Methods Mol Biol; 2010; 598():17-25. PubMed ID: 19967503
[TBL] [Abstract][Full Text] [Related]
7. Developmental immunotoxicology: focus on health risks.
Dietert RR
Chem Res Toxicol; 2009 Jan; 22(1):17-23. PubMed ID: 18783253
[TBL] [Abstract][Full Text] [Related]
8. Developmental immunotoxicity of chemicals in rodents and its possible regulatory impact.
Hessel EV; Tonk EC; Bos PM; van Loveren H; Piersma AH
Crit Rev Toxicol; 2015 Jan; 45(1):68-82. PubMed ID: 25372701
[TBL] [Abstract][Full Text] [Related]
9. Role of developmental immunotoxicity and immune dysfunction in chronic disease and cancer.
Dietert RR
Reprod Toxicol; 2011 Apr; 31(3):319-26. PubMed ID: 20854896
[TBL] [Abstract][Full Text] [Related]
10. Developmental immunotoxicity (DIT) in drug safety testing: matching DIT testing to adverse outcomes and childhood disease risk.
Dietert RR
Curr Drug Saf; 2008 Sep; 3(3):216-26. PubMed ID: 18691005
[TBL] [Abstract][Full Text] [Related]
11. Potential for early-life immune insult including developmental immunotoxicity in autism and autism spectrum disorders: focus on critical windows of immune vulnerability.
Dietert RR; Dietert JM
J Toxicol Environ Health B Crit Rev; 2008 Oct; 11(8):660-80. PubMed ID: 18821424
[TBL] [Abstract][Full Text] [Related]
12. Developmental immunotoxicity (DIT), postnatal immune dysfunction and childhood leukemia.
Dietert RR
Blood Cells Mol Dis; 2009; 42(2):108-12. PubMed ID: 19019708
[TBL] [Abstract][Full Text] [Related]
13. Recent progress and diverse effects in developmental immunotoxicology: overview of a symposium at the 46th Annual SOT Meeting, Charlotte, NC.
Rooney AA; Yang Y; Makris SL
J Immunotoxicol; 2008 Oct; 5(4):395-400. PubMed ID: 19404873
[TBL] [Abstract][Full Text] [Related]
14. Developmental immunotoxicity of atrazine in rodents.
Rowe AM; Brundage KM; Barnett JB
Basic Clin Pharmacol Toxicol; 2008 Feb; 102(2):139-45. PubMed ID: 18226067
[TBL] [Abstract][Full Text] [Related]
15. The mouse as a model for developmental immunotoxicology.
Holladay SD; Blaylock BL
Hum Exp Toxicol; 2002; 21(9-10):525-31. PubMed ID: 12458911
[TBL] [Abstract][Full Text] [Related]
16. Assessing a theoretical risk of dolutegravir-induced developmental immunotoxicity in juvenile rats.
Rhodes M; Laffan S; Genell C; Gower J; Maier C; Fukushima T; Nichols G; Bassiri AE
Toxicol Sci; 2012 Nov; 130(1):70-81. PubMed ID: 22790968
[TBL] [Abstract][Full Text] [Related]
17. Developmental immunotoxicity (DIT) testing of pharmaceuticals: current practices, state of the science, knowledge gaps, and recommendations.
Collinge M; Burns-Naas LA; Chellman GJ; Kawabata TT; Komocsar WJ; Piccotti JR; Shenton J; Wierda D
J Immunotoxicol; 2012; 9(2):210-30. PubMed ID: 22428536
[TBL] [Abstract][Full Text] [Related]
18. Developmental Immunotoxicity (DIT) Testing: Current Recommendations and the Future of DIT Testing.
vonderEmbse AN; DeWitt JC
Methods Mol Biol; 2018; 1803():47-56. PubMed ID: 29882132
[TBL] [Abstract][Full Text] [Related]
19. Possible role for early-life immune insult including developmental immunotoxicity in chronic fatigue syndrome (CFS) or myalgic encephalomyelitis (ME).
Dietert RR; Dietert JM
Toxicology; 2008 May; 247(1):61-72. PubMed ID: 18336982
[TBL] [Abstract][Full Text] [Related]
20. Toxicopathology of the developing immune system: investigative and development strategies.
Weinstock D; Lewis DB; Parker GA; Beyer J; Collinge M; Brown TP; Dybdal N
Toxicol Pathol; 2010 Dec; 38(7):1111-7. PubMed ID: 20962107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
